Apria, Inc.
http://www.apria.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Apria, Inc.
Device/Diagnostics Quarterly Deal Statistics, Q4 2013
Device companies finished 2013 strong, raising $1.2 billion in Q4, the highest quarter total of the year. CVS Caremark’s $2.1 billion buy of Apria’s infusion therapy business was the largest M&A of the year, and late-stage venture rounds dominated the $423 million total in diagnostics funding.
Medical Device Deals Update, January 2014
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced December 2013-January 2014.
Deals In Depth: November 2013
Egalet secured Shionogi as its first major partner in a deal focused on abuse-deterring forms of hydrocodone; to complement its specialty pharmacy portfolio, CVS acquired the infusion therapy business Coram for $2.1 billion. A $729 million debt offering by Incyte made up nearly one-third of the $2.5 billion in biopharma financing; and sources of public fundraising have been increasing over the past few months in the device industry, which raised $532 million.
PolyPharm Corp.
Service & Device to ensure patient compliance. PolyPharm's {MedManager} service links patients, physicians and payers with a patented hand-held pill dispensing device which alerts and instructs patients and also collects physiological data which can bedownloaded daily to medical personnel.
Company Information
- Industry
- Medical Devices
- Services
- Other Names / Subsidiaries
-
- Apria Healthcare Group Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice